SAFETY AND EFFICACY OF BEVACIZUMAB IN HIGH-RISK CORNEAL TRANSPLANT SURVIVAL

$2,345,534FY2012Department of the ArmyDOD

Massachusetts Eye And Ear Infirmary, Boston MA

Investigators